University Hospital Birmingham NHS Foundation Trust
Birmingham, West Midlands, B15 2TT, United Kingdom
NCT Number: NCT01028703
Studies of patients with established kidney disease, even when this is mild, appear to show that they are at high risk of heart failure, stroke and sudden cardiac death. This may be because kidney disease causes stiffening of the arteries in the body which means that the heart and brain are damaged by high blood pressure. By studying patients before and after the removal of a kidney (uni-nephrectomy) for transplantation the investigators will find out for the first time in man the effect of an isolated reduction in kidney function on the structure and function of the arteries and heart.
Hypotheses. An isolated reduction in GFR occuring after surgical uni-nephrectomy is associated with long term adverse cardiac and vascular effects which include:
1. Increased arterial stiffness and left ventricular mass 2. Abnormalities in left ventricular systolic and diastolic function 3. Increased oxidative stress, inflammation and collagen turnover
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Birmingham, West Midlands, B15 2TT, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Current nationally set Exclusion Criteria:
Time frame: 3 years
Time frame: 3 years
Time frame: 3 years
Time frame: 3 years
Time frame: 3 years
University Hospital Birmingham NHS Foundation Trust
Other
Does a Reduction in Renal Function Increase Arterial Stiffness and Left Ventricular Mass? - A Prospective Study of Kidney Donors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02579655
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT06428825
Arterial Hypertension, Cardiovascular Diseases
Mannheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT06150924
Albuminuria, Cardiovascular Diseases
Glendale, Arizona, United States
View Trial DetailsNCT04191824
Cardiovascular Diseases, Chronic Disease
Birmingham, Alabama, United States
View Trial Details